Exponent, Inc. (NASDAQ:EXPO) Shares Purchased by Tower Research Capital LLC TRC

Tower Research Capital LLC TRC raised its holdings in Exponent, Inc. (NASDAQ:EXPO) by 197.1% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 3,521 shares of the business services provider’s stock after buying an additional 2,336 shares during the quarter. Tower Research Capital LLC TRC’s holdings in Exponent were worth $314,000 at the end of the most recent quarter.

Other large investors have also modified their holdings of the company. Barclays PLC increased its position in Exponent by 219.0% during the third quarter. Barclays PLC now owns 96,526 shares of the business services provider’s stock worth $11,127,000 after purchasing an additional 66,263 shares during the last quarter. Allspring Global Investments Holdings LLC increased its holdings in shares of Exponent by 223.4% during the 4th quarter. Allspring Global Investments Holdings LLC now owns 6,158 shares of the business services provider’s stock worth $541,000 after buying an additional 4,254 shares during the last quarter. JPMorgan Chase & Co. raised its position in shares of Exponent by 63.6% in the 3rd quarter. JPMorgan Chase & Co. now owns 630,644 shares of the business services provider’s stock worth $72,701,000 after buying an additional 245,086 shares during the period. Argent Capital Management LLC boosted its holdings in Exponent by 17.3% in the fourth quarter. Argent Capital Management LLC now owns 28,323 shares of the business services provider’s stock valued at $2,524,000 after acquiring an additional 4,173 shares during the last quarter. Finally, KBC Group NV grew its position in Exponent by 62.4% during the fourth quarter. KBC Group NV now owns 2,274 shares of the business services provider’s stock valued at $203,000 after acquiring an additional 874 shares during the period. 92.37% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity at Exponent

In other news, VP Richard Reiss sold 1,736 shares of Exponent stock in a transaction that occurred on Wednesday, February 26th. The shares were sold at an average price of $85.93, for a total transaction of $149,174.48. Following the sale, the vice president now owns 1,800 shares in the company, valued at $154,674. This trade represents a 49.10 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Company insiders own 2.10% of the company’s stock.

Exponent Price Performance

Exponent stock opened at $76.78 on Friday. Exponent, Inc. has a 12 month low of $73.37 and a 12 month high of $115.75. The company has a market cap of $3.90 billion, a price-to-earnings ratio of 36.22 and a beta of 0.84. The stock’s 50-day moving average is $80.59 and its 200-day moving average is $89.84.

Exponent (NASDAQ:EXPO) last released its quarterly earnings data on Thursday, May 1st. The business services provider reported $0.52 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.48 by $0.04. Exponent had a net margin of 19.52% and a return on equity of 27.27%. The company had revenue of $137.44 million during the quarter, compared to analyst estimates of $134.63 million. During the same quarter in the prior year, the business earned $0.59 earnings per share. The business’s quarterly revenue was up .2% compared to the same quarter last year. Research analysts anticipate that Exponent, Inc. will post 1.98 EPS for the current year.

Exponent Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, June 20th. Stockholders of record on Friday, June 6th will be paid a $0.30 dividend. The ex-dividend date of this dividend is Friday, June 6th. This represents a $1.20 dividend on an annualized basis and a dividend yield of 1.56%. Exponent’s dividend payout ratio (DPR) is currently 56.60%.

About Exponent

Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.